News for OncoSil Medical Limited (OSL.AX)

Expectations of central bank interest rate cuts drove global markets higher, carrying the Australian market up for its sixth straight day of gains.

OncoSil Medical (ASX: OSL) has announced a 78% increase in the number of doses of its OncoSil single-use brachytherapy device used in commercial

The ASX200 is down 1.1 per cent – on par with futures’…

OncoSil's cancer device shows shrink in pancreatic tumours at a study conducted at the Royal Adelaide Hospital in South Australia

OncoSil Medical (ASX:OSL) confirmed that the first patient treatment using the OncoSilTM device has now been dosed and complete in London

The ASX200 has closed down .56 of a per cent with IT…

The ASX200 is down nearly .7 of a per cent – almost…

OncoSil Medical doses pancreatic cancer patients in Austria, and sets its sights on additional European expansion.

The ASX200 fell today, as predicted, losing nearly one and a quarter…

The ASX200 has dropped as expected, down 1.1 per cent mid-session with every sector in the red.

OncoSil Medical (ASX:OSL) has announced positive developments regarding potential funding for its OncoSil device in Germany and a new distribution agreement in Turkey.

The ASX opened lower this morning, while majority of the sectors dragged.

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

It's Thursday on Stockhead. The ASX200 closed down 0.08% on Wednesday and today's all about easing inflation and ASX gold.

While the goldies put on a +2.0% show, the rest of the market struggled today, leaving the benchmark down 0.08% on another wan Wednesday.

It's Wednesday on Stockhead. A Big CPI read for fans of inflation. We're in India, on lithium and digging for gold, as per raison d'être.

The ASX closed 0.11% lower today as falling iron ore prices made everyone sad, except for REE-hunter Larvotto which picked its time to shine.

The ASX has whip-sawed its way to a minor pre-lunch win, while Mamba's surge has continued despite yet another fall for Materials.

The ASX dipped 0.3% by lunchtime, but Elmore's come out of suspension and into the arms of hungry investors, climbing 50% already today.